Heart disease is a major cause of morbidity and mortality throughout the world. Some cardiovascular conditions can be modulated by lifestyle factors such as increased exercise or a healthier diet, but many require surgical or pharmacological interventions for their management. More targeted and less invasive therapies would be beneficial. Recently, it has become apparent that epicardial adipose tissue plays an important role in normal and pathological cardiac function, and it is now the focus of considerable research. Epicardial adipose tissue can be studied by imaging of various kinds, and these approaches have yielded much useful information. However, at a molecular level, it is more difficult to study as it is relatively scarce in animal models and, for practical and ethical reasons, not always available in sufficient quantities from patients. What is needed is a robust model system in which the interactions between epicardial adipocytes and cardiac myocytes can be studied, and physiologically relevant manipulations performed. There are drawbacks to conventional culture methods, not least the difficulty of culturing both cardiac myocytes and adipocytes, each of which has special requirements. We discuss the benefits of a three-dimensional co-culture model in which in vivo interactions can be replicated.
Introduction
The mammalian heart is surrounded by layers of visceral fat known as paracardial adipose tissue. The outermost layer of adipose tissue, the pericardial layer, can cover the entire structure and is separated from the surface of the heart by a layer of connective tissue, the fascia. Beneath this fascia, however, is another layer of fat that is directly apposed to the heart, with no physical barrier between the two: the epicardial adipose tissue (EAT, see Figure 1 ). EAT is located primarily around cardiac blood vessels, in the atrioventricular cleft, and around the right ventricle; it can also extend into the myocardium, and this is not in itself indicative of disease (Rabkin, 2007) . Studies with post mortem samples have shown that EAT can cover 80% of the heart and contribute up to 20% of ventricular mass in normal individuals (Rabkin, 2007; Chechi and Richard, 2015) . Epicardial adipocytes have many characteristics of white adipocytes, but produce UCP-1, a marker characteristic of brown adipocytes (Nicholls et al., 1978; Sacks et al., 2009; Sacks et al., 2013) . Thus some authors have described this tissue as 'beige' or 'brite' adipose tissue (Gaborit et al., 2013; Chechi and Richard, 2015) .
The functional relationship between the heart and the overlying EAT is important; indeed, the adipocytes within EAT, and their products, are critical to the function of the heart. Epicardial adipocytes are an essential source of free fatty acids (FFA), which cardiac myocytes preferentially utilize for energy (Marchington et al., 1989) . EAT also provides thermal and physical protection for the heart (Rabkin, 2007; Chechi and Richard, 2015) and, importantly, is a rich source of adipokines that can interact with cardiac myocytes and other tissues in a paracrine manner to promote efficient cardiac function (Talman et al., 2014) . However, these beneficial functions of EAT can be diminished or negated by the release of signals that evoke pathological changes in coronary blood vessels and cardiac myocytes. Thus, there is interest in investigating interactions between EAT and the heart. Such studies could identify clinically relevant processes or molecules that might allow pharmacological interventions for a range of cardiovascular diseases.
A considerable amount of work has shown that adipose tissue is biochemically specialized in a site-specific way relating to its function (MacQueen et al., 2000; Mattacks et al., 2004; Westcott et al., 2006; Pond, 2009 ). There are clear and consistent differences in the triacylglycerol (TAG) fatty acids found in adipocytes from different anatomical locations, even within the same adipose depot. Therefore, it is not surprising that patterns of gene expression and proteins secreted also differ between adipocytes in a site-specific way. Zdychova et al. (2014) studied the secretome of adipocytes explanted and cultured from EAT, renal adipose tissue and superficial adipose tissue (SAT). Mazurek et al. (2003) were the first to show differences in cytokines secreted by EAT in patients with coronary artery disease (CAD), and found a higher number of pro-inflammatory cytokines secreted by the EAT. Compared with SAT, the transcriptome of the EAT is typical of that from an inflammatory tissue
Figure 1
Diagram illustrating the positions of epicardial and pericardial fat depots in the heart. Note the intimate association between the epicardial fat and the myocardium. Reprinted by permission from Macmillan Publishers Ltd: Nature Reviews Endocrinology. (Iacobellis, G. (2016) Nat Rev Endocrinol 11(6): 363-71). Copyright (2016).
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Catalytic receptors (McAninch et al., 2015) . Not only are the secretome and transcriptome different between SAT and EAT but Gaborit et al. (2015) have also recently characterized molecular differences between various regions of the EAT (peri-ventricular, peri-coronary and peri-atrial). In general, pathological conditions such as CAD result in a down-regulation of genes involved in intracellular trafficking, proliferation and protein catabolism, and an up-regulation of genes involved in inflammatory and immune responses.
The structure and function of EAT
Epicardial fat is present from birth in humans and its mass increases with age until between 20 and 40 years of age after which time it becomes independent of age (Rabkin, 2007) . It is a dynamic fat depot, and can increase, or remodel, in conditions such as obesity and inflammation (Hassan et al., 2012; Iacobellis, 2015; Kusayama et al., 2015; McAninch et al., 2015; Matloch et al., 2016; Samanta et al., 2016) . During development, EAT arises from the splanchnopleural mesodermal lineage, the same origin as mesenteric and omental fat (Marchington et al., 1989; Gaborit et al., 2013) , and it therefore shares the same lineage as cardiac myocytes (Martinsen and Lohr, 2005) . The two tissues are closely related in that they share circulation and innervation (Marchington et al., 1989; Arora et al., 2003) . Intrinsic cardiac neurons and ganglionated plexuses, containing adrenergic and cholinergic neurons, are embedded in EAT (Arora et al., 2003; White, 2016) . Zhou et al. (2014) showed that the cardiac ganglionated plexus in EAT incorporates the autonomic innervation (both sympathetic and parasympathetic) of the heart, and affects atrial function. Moreover, Balcioglu et al. (2015) found that a sympatho-vagal imbalance, a predictor of arrhythmia, was associated with EAT thickness. Parisi et al. (2016) also found that in patients with heart failure, there was cardiac sympathetic denervation that could be correlated with increased epicardial adipocyte volume. EAT is not just a passive supporting structure for cardiac innervation but is innervated in its own right. Zeng et al. (2015) have shown, although not in epicardial adipocytes, that sympathetic innervation of adipose tissue mediates the lipolytic action of leptin. Adipocytes from many sources have been shown to be sensitive to both β-and α-adrenoceptor stimulation, which directly increase lipolysis (Mattacks and Pond, 1999; Mattacks et al., 2005) thus providing an increased supply of FFA for the heart's energy requirements (see above).
The thickness of EAT is a predictor for several types of cardiovascular disease signs such as stenosis, calcification, atheroma, stiffness, plaque development and arrhythmias including atrial fibrillation (Mookadam et al., 2010; Hassan et al., 2012; Gaborit et al., 2013; Hatem and Sanders, 2014; Furuhashi et al., 2016; Siegel-Axel and Haring, 2016; Wong et al., 2016) . Moreover increased EAT volume is associated with a lengthened PR interval (Hung et al., 2015) , suggesting that EAT can interfere with electrical conduction through the heart. Recently, cognitive decline and dementia have also been linked to an increased EAT thickness (Mazzoccoli et al., 2014; Viscogliosi et al., 2016) . However, EAT thickness varies between ethnicities, so no specific threshold value for clinical significance has yet been established (Willens et al., 2008; Pierdomenico et al., 2013; Yañez-Rivera et al., 2014) . The relative amount of EAT varies between species. In general, larger mammals have more prominent EAT than smaller animals like rodents (Marchington et al., 1989) . Recent studies have shown that mice possess a limited amount of EAT, located in the atrio-ventricular groove (Yamaguchi et al., 2015) . Nevertheless, it is difficult to obtain large amounts of EAT from rodents, limiting their use as a source of tissue for ex vivo and in vitro investigations.
In common with other visceral fat depots, EAT has a function in lipid trafficking, and its mass is correlated with whole-body adiposity (Iacobellis et al., 2004) . However, the mean adipocyte volume is around half the value found in other visceral adipose depots (Marchington et al., 1989) , suggesting that the primary function of epicardial adipocytes is not fat storage. Moreover, even though the adipocytes in EAT can take up fatty acids from the circulation, convert them to TAG, and subsequently release them after lipolysis, these processes are not regulated by insulin in the same way as in adipocytes from other depots (Burgeiro et al., 2016) . Epicardial adipocytes are specialized for their role supporting heart muscle (Marchington and Pond, 1990) . EAT is not simply a benign store of excess fat, as it is metabolically active and interacts with surrounding tissues, including the contractile cardiac myocytes within the heart (Gaborit et al., 2013) . It is this last point that is the focus of our work, as we seek to understand how the metabolic activities of epicardial adipocytes support, or in pathological conditions dysregulate, cardiac myocyte function. Although the metabolic crosstalk between EAT and the myocardium is poorly understood, there is compelling evidence that it exists and is important in health and disease. Glucose uptake and lipid metabolism in EAT are impaired in patients with heart failure and these effects are modulated in patients who also had diabetes (Burgeiro et al., 2016) . There is a growing body of evidence of changes in gene expression in EAT that can be linked to cardiovascular disease (Salgado-Somoza et al., 2012; Agra et al., 2014a, b) . This topic is extensive and has recently been systematically reviewed by Maghbooli and Hossein-Nezhad (2015) . These authors concluded that the 'hub' genes for EAT involvement in cardiovascular disease were those for IL-6 and p53, with the latter gene also being identified as of major importance in CAD (Agra et al., 2014b) .
Like other cells that have a high demand for fatty acids (such as T cells containing a Gall body), cardiac myocytes contain fat droplets (Iozzo, 2011) . It is thought that this sequestration of fatty acids allows them to be used rapidly when a physiological need arises. The particular mix of fatty acids sequestered varies with cell type and anatomical site (MacQueen et al., 2000; Pezeshkian et al., 2009; Pond, 2009) , and it would be interesting to measure the particular fatty acid mix found within cardiac myocytes and compare it with the fatty acid profiles of EAT. Burgeiro et al. (2016) reported that the fatty acid composition of epicardial adipocytes is altered in patients with heart failure and diabetes and that this might suggest related changes in the fatty acid composition of cardiac myocytes in pathological states.
Overview of adipokines
It is well known that adipocytes secrete signalling molecules, and other factors that affect the cardiovascular system. Adipokines are frequently measured in the systemic circulation (see Iacobellis, 2015) , but these measurements cannot address the paracrine interactions that take place at a local level. It is not yet clear which of the cohort of paracrine messengers cause particular pathological changes in cardiac myocytes. Moreover, it has been demonstrated that the secretome of adipocytes can change under pathological conditions such as inflammation, thereby promoting the release of harmful signals (Kusayama et al., 2015; Venteclef et al., 2015; Furuhashi et al., 2016; Iacobellis, 2016) . Adipokines have been linked to many pathologies (Deng and Scherer, 2010b) , but the mechanisms involved remain to be elucidated.
The in vivo effects of adipokines are complex and not easily predictable. For example, the effects can be dose-or concentration-dependent, or may only become obvious if a particular combination of adipokines is present. As an example, the cardioprotective effect of omentin-1 only becomes obvious when cardiac function is impaired, as in diabetes mellitus (Greulich et al., 2013) . Interestingly, the baseline adiponectin concentration in EAT is lower than that found in other fat depots (Elie et al., 2016) , although adiponectin can partly rescue the diminished cardiac contraction observed in obese mice (Dong and Ren, 2009 ). Both omentin-1 and adiponectin are considered to be cardioprotective not only because of their direct effects on cardiac myocytes but also because they reduce inflammation, improve endothelial function and reduce oxidative stress Matloch et al., 2016) . The cardioprotective function of adrenomedullin is thought to originate in its vasodilatory, anti-inflammatory and antioxidative effects, and in its inhibition of hypertrophic remodelling in a disease situation (Silaghi et al., 2007; Fosshaug et al., 2015) . Some adipokines, such as resistin, activin A and fatty acid binding protein 4 (FABP4) (Lamounier-Zepter et al., 2009; Look et al., 2011; Venteclef et al., 2015) have detrimental effects, while others, such as leptin and apelin, can show either helpful or deleterious effects depending on their concentration (Look et al., 2011; Ghantous et al., 2015) . As well as acting on myocytes, some adipokines affect the cardiovascular endothelia. For example, orosomucoid can increase proliferation in endothelial cells and therefore promotes healing of damaged endothelia (Fandino-Vaquero et al., 2014) . It is unclear what provokes changes in the secretome of EAT to tip the balance between the release of deleterious or beneficial signals. However Fernandez-Trasancos et al. (2016) showed in vitro that inflammatory conditions, and glucose levels, affected adiponectin expression in EAT. The reported effects of a number of adipokines are summarized in Table 1 .
EATing for a healthy heart
EAT is critical for the function of a healthy heart by supplying FFA as the preferred energy source for cardiac myocytes and by acting as a sink, when there is an excess of circulating FFA. Nevertheless, much research has established that through its secretion of pro-inflammatory adipokines, EAT is significantly associated with CAD and atherosclerosis (Shimabukuro et al., 2013; Talman et al., 2014; Furuhashi et al., 2016) . In fact, the EAT around the coronary vessels can co-localize with areas of plaque development (Prati et al., 2003; Alexopoulos et al., 2010) . Peri-coronary EAT shows an up-regulation of genes regulating sphingosine metabolism, suggesting a role for EAT in atherogenesis . While it is clear that a compromised blood supply can affect cardiac function, our interest lies more with the possible direct effects of EAT and its adipokines on the cardiac myocytes and the disruption to regular beating that can result in arrhythmias, such as atrial fibrillation.
As noted above, EAT is a dynamic depot and its size is positively correlated with whole-body fat and obesity. Interestingly, changes in the structure and function of cardiac myocytes, and the pro-inflammatory status of the adipocytes caused by a high-fat diet can precede the onset of weight gain and obesity (Goncalves et al., 2016) . Also, during weight loss protocols, EAT reduces in thickness before abdominal fat is reduced (Iacobellis, 2015) . This suggests that EAT activity is highly sensitive to nutritional status and that the epicardial adipocytes may act as a sentinel for cardiac dysfunction.
Throughout a typical human lifetime, the heart beats 2 million times (Bers, 2002) . The contraction of the heart is triggered by action potentials that propagate from the sinoatrial node in the right atrial chamber. As an action potential sweeps across the atrial and ventricular chambers, it causes the membrane to depolarise, opening voltage-operated calcium (Ca 2+ ) channels and causing a Ca 2+ influx into the cell.
Within the cell, this Ca 2+ signal is amplified by Ca 2+ -induced Ca 2+ release via ryanodine receptors (RyRs) on the sarcoplasmic reticulum, thus causing a global Ca 2+ signal that triggers the intracellular contractile machinery to engage, so that the cells shorten and generate the force to propel blood to the lungs and body. This process is often referred to as excitation-contraction coupling (Berridge, 2003; Dobrzynski et al., 2013) and is illustrated in Figure 2 . For a regular heartbeat, each action potential must cause a rapid, transient, Ca 2+ rise within every cardiac myocyte. It is believed that increased automaticity (spontaneous depolarisation of myocytes), acute triggered activity (spontaneous electrical events following recovery from an action potential) or re-entry circuits (return of an electrical impulse to cardiac cells following a refractory period) contribute to the development of arrhythmia. The underlying causes of all these pro-arrhythmic conditions are not fully understood, but substantial evidence has implicated a higher incidence of spontaneous Ca 2+ signals as a likely cause (Bers, 2008; Heijman et al., 2012; Voigt et al., 2012) . Generally, pro-arrhythmic processes can be classified into electrical and structural remodelling. Electrical remodelling encompasses changes in the ion channel expression, changing the myocyte's response to action potentials and leading to automaticity and triggered activity. Electrical remodelling can occur very rapidly, and is usually reversible. Recent evidence suggests that FFA can cause electrical remodelling in the atria (O'Connell et al., 2015) . In contrast, structural remodelling takes longer to develop, and 
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Continues is usually irreversible. The most common structural remodelling process is fibrosis, the formation of fibrotic tissue between cardiac myocytes. As a consequence of fibrosis, the propagation of electrical signals is disrupted because of the presence of non-conducting tissue. Instead of propagating into the next cell, electrical signals spread sideways or backwards and can enter the same cell again, leading to the development of perpetuating rotors of electrical signals, and consequently to arrhythmia (Eisner, 2014; Heijman et al., 2014; Lip et al., 2016) . Of interest here is the fatty infiltration between the cardiac myocytes, seen when excess EAT is present, that can transform into fibrotic tissue. Adipokines and cytokines secreted from EAT can induce fibrosis (Haemers et al., 2015; Venteclef et al., 2015) and alter the Ca 2+ handling, and thus the contractions, of cardiac myocytes (Hatem et al., 2016) . It appears that the correct functioning of the EAT is essential for effective cardiovascular activity, and the interactions between EAT and cardiac myocytes represent an important therapeutic target.
Approaches to studying EAT
EAT has historically been a somewhat neglected tissue (Rabkin, 2007) , but the advent of techniques such as echocardiography made it easy to identify and quantify. Extensive work by Iacobellis and others (Iacobellis et al., 2003 (Iacobellis et al., , 2005 (Iacobellis et al., , 2009a McAninch et al., 2015; Elisha et al., 2016) showed that EAT varies between individuals in thickness and volume, and that the thickness can be correlated with disease states. For example, there is significantly more EAT in subjects with metabolic syndrome or CAD than in those without these conditions (Sade et al., 2009; Pierdomenico et al., 2013) . The advantage of echocardiography is that it is non-invasive (although it may be coupled with more invasive techniques such as angiography), relatively cheap and widely available (Parisi et al., 2016) . Its disadvantage is that the studies are observational, giving a 'snapshot' of patients who have already presented with a suspected or actual cardiopathology. Also, using this technique, it can be difficult to define the border between epicardial and pericardial fat, which can potentially generate misleading data (Hatem et al., 2016) . Other fat depots that would be useful as controls are located in different parts of the body, so the appropriate controls can usually not be obtained from the same patient due to the increased risks and length of the necessary surgery (Fain et al., 2010; Gaborit et al., 2015) . One of the few prospective studies undertaken so far reported a correlation of peri-atrial EAT thickness with the future onset of atrial fibrillation in patients who did not show any signs of such fibrillation at the time of the scan (Nakanishi et al., 2012) . Although the reproducibility of echocardiographic analysis and interpretation has been questioned (Wong et al., 2016) , a good correlation between echocardiography and other techniques for measuring EAT thickness in specific areas has been reported (Song do et al., 2015) .
Other types of imaging studies have been undertaken, such as CT (Sarin et al., 2008; den Dekker et al., 2014; Harada et al., 2014; Hung et al., 2015; Kitagawa et al., 2015) , PET-CT (Janik et al., 2010; Bakkum et al., 2015) , MRI (Kim et al., 2012; Gaborit et al., 2013; Hua et al., 2014) and fluoro-deoxyglucose PET (Kaushik et al., 2014; Mazurek et al., 2014) . The principal advantage of all these Figure 2 Model of potential interactions between cardiac excitation-contraction coupling and EAT. The Figure illustrates where adipokines might affect the excitation-contraction coupling of cardiac myocytes. Panel A shows the excitation-contraction coupling in cardiac myocytes in a healthy situation. Arrival of an action potential (ΔV m ) opens voltage-gated Ca 2+ channels in the sarcolemma, causing the influx of Ca 2+ ions. The increase in the intracellular Ca 2+ concentration activates Ca 2+ -activated Ca 2+ -release via RyRs localized on the sarcoplasmic reticulum, causing the myocyte to contract. Adipocytes in the EAT are in contact with the cardiac myocytes, and can reach between them. They secrete, for example, omentin-1, apelin and adiponectin, which act on the cardiac myocytes in a positive manner, sustaining their regular contractions. They also affect processes other than the contraction of myocytes, for example, gene expression, anti-inflammatory functions and protection from ROS. Panel B shows changes occurring in a disease situation, where the secretome from the EAT is remodelled. Adipocytes infiltrate deeper between the myocytes and release different adipokines, for example, activin A, leptin and FABP4. Activin A activates fibrosis, which in turn hinders the smooth propagation of action potentials and can cause pro-arrhythmic re-entry circuits. FABP4 and apelin reduce the contraction strength of myocytes. Adipokines can increase intracellular ROS production, causing spontaneous Ca 2+ release from the SR, further contributing to arrhythmia.
Adipokines in a diseased state cause a pro-inflammatory situation, including the recruitment and activation of macrophages, and change the pattern of gene expression. Several of the signalling pathways and receptors activated by adipokines have not yet been identified. methods is that they are non-invasive, and there is generally much better resolution than in echocardiographic studies. Three-dimensional (3D) and volume measurements, rather than simply thickness, are possible: both CT and MRI can specifically measure peri-coronary EAT, which is an important correlate of atherosclerosis (Iacobellis, 2016; Wong et al., 2016) . CT studies have confirmed an association between atherosclerosis, myocardial infarction and EAT (Mahabadi et al., 2013; Mahabadi et al., 2014) . However, CT uses radiation, so is not suitable for follow-up studies requiring repeated measurements. The main drawback of these techniques is that they require expensive equipment and are neither cheap nor easy to access. This is particularly the case for cardiac MRI, regarded as the gold standard because it gives good 3D imaging, does not use radiation and is the only method to have been verified ex vivo. MRI can reliably detect fibrosis and fat depots (Wong et al., 2016) . Therefore, there is a trade-off between availability and accuracy when considering imaging methods. Post mortem examination of patients who have died from other causes can provide some indications of the situation in 'normal' (albeit dead) individuals (Gho et al., 2014; Furuhashi et al., 2016) . A drawback to post mortem studies is that the condition that killed the individual may itself have affected adipose tissue distribution, giving some uncertainty as to what actually constitutes 'normal'. Even when samples can be obtained from live patients, they are usually small and may allow only the analysis of mRNA levels, not the actual expressed protein levels. For ethical reasons, it is currently difficult to obtain data from control patients, although this may change with the advent of large-scale prospective studies.
Going beyond the identification and quantitation of EAT, many studies of this fat depot have involved molecular and biochemical studies using either blood or tissue biopsies, obtained during elective cardiovascular surgery procedures. These studies have variously used ELISA (Mazurek et al., 2003; Gao et al., 2011; Sacks and Fain, 2011; Teijeira-Fernandez et al., 2011; Fosshaug et al., 2015; Venteclef et al., 2015; Elie et al., 2016) , PCR (Mazurek et al., 2003; Fain et al., 2010; Gao et al., 2011; Teijeira-Fernandez et al., 2011; Fosshaug et al., 2015) , miR analysis (Vacca et al., 2016) , transcriptome and secretome analysis (Guauque-Olarte et al., 2011; Imoto-Tsubakimoto et al., 2013; Gaborit et al., 2015; McAninch et al., 2015; Venteclef et al., 2015) to show that the molecular profile of EAT is different from that of other adipose depots, and can change during physiological challenges affecting the heart. This large body of data supports the site-specific, localized role played by EAT, but does not elucidate the question of whether the observed changes are the cause or the effect of physiological disturbance. In order to get around this problem, a model system amenable to experimental manipulation is required. Although clinicians are frequently unwilling to translate data derived from animal studies to humans, it remains the case that whole animals, or cells derived from them, constitute a rich source of information and data, and can frequently provide valid experimental models. We discuss some of the options below.
Studying EAT-cardiac myocyte interactions using animal models Some of the earliest studies of EAT (Marchington et al., 1989; Marchington and Pond, 1990 ) used short-term cultures of tissue explants from rodents to study the biochemistry and fat trafficking in epicardial adipocytes. Animal tissue has also been cultured for this purpose by Greulich et al. (2011) (guinea pigs and rats), Chilukoti et al. (2015) (pigs and rats) and Lage et al. (2015) (neonatal rats and cell lines). The availability of a range of mouse knockout strains has also been exploited by Nevelsteen et al. (2013) , studying cardiac myocyte function and obesity, although not specifically EAT, and by Castro et al. (2015) . This group reported on a wide-ranging project in which they studied the metabolomics by MS-NMR and looked at circadian rhythms of brown and white adipose tissue.
In an attempt to elucidate the role of adipokines in cardiac dysfunction, many in vitro studies have added purified adipokines to cardiac myocytes in culture, and measured the effects on their function. A drawback of these studies is that the adipokine effects may be complex and are often concentration-dependent (see above): for example, the cardioprotective effect of omentin-1 is only evident when applied in combination with inflammatory interleukins (Greulich et al., 2013) . It is not easy to replicate, in culture, the relevant physiological conditions, in which there may be subtle differences in adipokine and other cytokine concentrations. One approach to resolving this problem has been to use ex vivo cultured EAT biopsy samples to prepare conditioned media for adding to established cultures of (usually) rodent cardiac myocytes. Such an approach has been used to analyse the secretome, and to test for structural and functional effects of the EAT on the cardiac myocytes. Such studies identified activin A as the major factor causing fibrosis .
It is known that both a high-fat diet and diabetes mellitus cause deterioration in heart function. Medium conditioned by the EAT of animals eating a high-fat diet reproduced these effects (reduced contraction strength and Ca 2+ amplitude in isolated rat cardiac myocytes), whereas medium conditioned by SAT did not (Greulich et al., 2011) . In a later study, the authors found that the reduced cardiac function was caused by a lack of omentin-1, which in healthy animals protects the cardiac myocytes from the detrimental effects of cytokines like interleukins. Omentin-1 cannot fulfil this function when its levels are reduced in type 2 diabetes mellitus (Greulich et al., 2013) . Other cardioprotective effects of omentin-1 have been mentioned in Table 1 . Another adipokine that impairs cardiac function, specifically the contractility of cardiac myocytes, is FABP4, which was identified and its effects characterized by Lamounier-Zepter et al. (2009 . The detrimental effects of FABP4 are potentiated in the presence of epoxyeicosatrienoic acids, which are also secreted by the EAT. Although many such studies have elucidated the role of EAT and related it to cardiac function, little has yet been done to elucidate the physiological interplay between these tissues. In order to do this rigorously, a culture methodology that is robust, reproducible and physiologically relevant must be adopted. Conventional two-dimensional (2D) culture can be, and has been, used, but although it offers the opportunity for extensive experimental manipulations, it is a poor representation of the in vivo physiological situation. While a cardiac myocyte culture, using neonatal cells, is relatively straightforward to set up, it is difficult to mimic any effects of neighbouring adipocytes. Using adipocyte-conditioned media, as described above, means that cardiac myocytes are presented with a bolus of adipocyte-derived molecules, which, although more representative than the addition of isolated adipokines, are nevertheless likely to be at different concentrations from those present in the paracrine flow that occurs in vivo. In addition, labile molecules will not be adequately represented in conditioned medium, so their effects can be missed. From a clinical perspective, it is necessary to find treatments that allow the long-term management of adipocyte-cardiac myocyte interactions. Acute responses evoked by bolus additions of adipocyteconditioned medium can pinpoint factors that affect cardiac myocyte function, but it is not a method that allows prolonged study, and management, of cardiac myocyte functionality and viability in the presence of persistent paracrine signals. For these reasons, we consider that a better method for studying interactions between cell types may be to use 3D co-cultures, and we elaborate on this below.
The 3D approach
Primary adipocytes are difficult to work with in vitro, as they are very fragile. They cannot be retained in 2D cultures because their buoyant density decreases as they accumulate TAG, causing them to detach from the culture substrate and thus they are lost during medium changes. Furthermore, only cardiac myocytes prepared from neonatal rodents can be kept in culture for prolonged periods of time, as cardiac myocytes isolated from adult animals de-differentiate quickly after being isolated and placed in 2D culture. However, in 3D culture, it is possible to keep cardiac myocytes differentiated and spontaneously beating for a period of up to 6 weeks (Burridge et al., 2014) . Their phenotype resembles that of a mature differentiated myocyte when they are kept in a 3D culture that has a stiffness mimicking that of the heart (Engler et al., 2008; Pontes Soares et al., 2012; Bian et al., 2014) . Similarly, adipocytes show good survival in 3D cultures, and retain the in vivo structural and functional characteristics of mature adipocytes (Daya et al., 2007) . Because collagen gels are translucent, 3D co-cultures are amenable to microscopic analyses that allow real-time measurement of cellular responses and phenotype. Contractions of the whole gel or of cells inside the gel can be measured by force transducers or by visualizing cell contraction, and intracellular Ca 2+ changes can be monitored using fluorescent Ca 2+ sensitive dyes (Shapira-Schweitzer et al., 2009; Ye et al., 2011; Bian et al., 2014; Chiu et al., 2014) . Furthermore, the culture supernatants can be assayed for secreted molecules, and the two cell types can be independently recovered for proteomic, genomic and molecular analysis (Daya et al., 2007; Phillips and Brown, 2011; Georgiou et al., 2015) . Thus, primary cardiac myocytes and adipocytes can be co-cultured for prolonged periods of time, allowing paracrine signalling to occur, and the interactions between these cells to become established in a way that closely models the in vivo situation. The functionality and viability of cells within the 3D collagen matrix can be closely monitored, and both cell types can be recovered separately for subsequent in vitro molecular analysis. By culturing adipocytes and cardiac myocytes within a 3D co-culture model, we can better mimic the normal concentrations and rates of paracrine delivery of signals between these cells.
Conclusions
The EAT is now well established as an important modulator of cardiac function. Changes in EAT metabolism can be associated with a number of pathologies both in human patients and in animal models, and it seems clear that this relationship is a strong candidate for therapeutic intervention. However, the relationship is complex. Not only does the particular mix of paracrine signals vary with physiological state but the anatomical location within the EAT also appears to play a part as well. Like all adipose tissue, the EAT demonstrates site-specific function.
Although there have been many important contributions towards elucidating the interplay between cardiac myocytes and EAT, more questions remain unanswered. Key to identifying the underlying mechanism(s) is the deployment of appropriate experimental techniques that will allow experimental manipulation of the relationship over the short and medium term. Only then will it be apparent whether the changes seen in EAT metabolic activities are the cause or the result of the pathologies. Current technologies range from the 'snapshots' provided by imaging and analysis of biopsy samples from patients through to highly reductionist in vitro techniques. One limitation of human studies will always be the lack of 'healthy EAT' samples as a control. Our preference is to develop a 3D co-culture system in which both cardiac myocytes and adipocytes can flourish together over several weeks, and in which experimental modifications and subsequent analysis are straightforward. 
